Background: A complex of MCM proteins is implicated in ensuring that DNA replicates only once in each cell cycle, by 'replication licensing'. The nuclear membrane is also implicated in replication licensing, but the relationship between the MCM proteins and the nuclear membrane is unclear. Here, we investigate the relationship between XMCM3 (a component of the Xenopus MCM complex), nuclear envelope permeability and the initiation of DNA replication once per cell cycle. Results: Our results show that the nuclear envelope does not prevent the entry of XMCM3 into the nucleus, but that it does prevent the binding of XMCM3 to chromatin. We have also identified another component of the Xenopus MCM complex as a homologue of the Schizosaccharomyces pombe protein Cdc21. XMCM3 does not preferentially co-localize with sites of DNA replication. Instead, it is almost uniformly distributed on chromatin and is suddenly lost during replication. XMCM3 crosses intact nuclear membranes of G2-phase HeLa cells but cannot then bind to chromatin. Permeabilization of the nuclear envelope allows the binding of XMCM3 to G2-phase chromatin. We have therefore resolved replication licensing into two stages. The first requires the entry of a cytosolic 'loading factor' that is excluded by the nuclear membrane; subsequently, MCM3 can bind to chromatin in the presence or absence of a nuclear membrane, but only if the loading factor has gained access in the absence of the membrane.
nuclear membranes of G2-phase HeLa cells but cannot then bind to chromatin. Permeabilization of the nuclear envelope allows the binding of XMCM3 to G2-phase chromatin. We have therefore resolved replication licensing into two stages. The first requires the entry of a cytosolic 'loading factor' that is excluded by the nuclear membrane; subsequently, MCM3 can bind to chromatin in the presence or absence of a nuclear membrane, but only if the loading factor has gained access in the absence of the membrane.
Conclusions:
The Xenopus MCM complex contains homologues of yeast MCM2, MCM3, MCM5 and Cdc21 proteins. XMCM3 is displaced from chromatin during replication. The nuclear envelope allows entry of XMCM3 into the nucleus, but regulates its binding to chromatin; binding requires a loading factor which cannot cross the nuclear envelope. Based on these results, we present a two-stage model for replication licensing.
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Background
In eukaryotic cells, DNA replication is regulated so that the genome is replicated once and only once per cell cycle; reinitiation of replication does not occur until the next cell cycle. Early cell fusion experiments demonstrated a clear difference between pre-replicative (G1 phase) and post-replicative (G2 phase) nuclei. When G1-or G2-phase cells are fused with S-phase cells, the G1 nucleus can replicate its DNA but the G2 nucleus replicates only after the hybrid cell has passed through mitosis [1] . Experiments in vitro using a cell-free system derived from Xenopus egg extracts show that nuclear membrane breakdown is the only feature of mitosis required for rereplication to be permitted [2] . It has been suggested that the nuclear membrane might prevent access to chromatin of a hypothetical licensing factor that is essential for the initiation of replication. This factor would gain access to chromatin only during mitotic nuclear membrane breakdown, and would be inactivated during S-phase. The integrity of the nuclear membrane would then prevent further rounds of replication taking place until after mitosis [2] . Evidence for the existence of at least one positive factor that behaves in this way has been presented [3] [4] [5] .
Although licensing factor has yet to be described in molecular terms, genetic screens in budding yeast have been helpful in identifying candidate molecules. The MCM2, MCM3 and MCM5 genes were originally isolated because mutations in them affect the ability of yeast cells to retain minichromosomes during successive cell cycles [6] . The minichromosome maintainance defect is specific to individual autonomously replicating sequences (ARSs), indicating possible interactions of the MCM proteins with replication origins [6, 7] . MCMs 2, 3 and 5 are highly homologous to each other, and define a family of proteins involved in replication [8] . Homologues of each family member are found in higher organisms, as well as in fission yeast [8] [9] [10] [11] [12] . Screens for mutants defective in the cell cycle have identified other members of the MCM family, such as Cdc21 [13] , CDC47 [14] and CDC46 [15] , which was later shown to be identical to MCM5 [16] . MCM2, MCM3 and MCM5/CDC46 are found in the nucleus during mitosis, persist in the nucleus during G1 phase, and disappear from the nucleus at the beginning of S phase [15, 17] . These three proteins therefore satisfy two of the attributes of licensing factor: involvement in DNA replication and cell-cycle dependent nuclear localization.
The requirement for the MCM family members in yeast DNA replication is consistent with the observation that S phase is disrupted by the microinjection of anti-MCM2 or anti-MCM3 antibodies into cultured mammalian cells [11, 18] . However, immunolocalization studies of MCM homologues in higher organisms show that the proteins are exclusively nuclear throughout the cell cycle ( [10, 11, 18, 19] ; T. Krude, C. Musahl, R.A.L. and R. Knippers, personal communication).
A Xenopus homologue of yeast MCM3 (XMCM3) has been cloned and shown to be involved in licensing DNA for replication [20] [21] [22] . XMCM3 binds to G-phase chromatin, is displaced during replication and is absent from G2-phase chromatin [20] [21] [22] . Consistent with these observations, murine MCM3 and human MCM2, MCM3, CDC46 and CDC21 homologues are also displaced from chromatin during S phase ( [18, 23] ; T. Krude, C. Musahl, R.A.L. and R. Knippers, personal communication). The binding of XMCM3 to chromatin is essential for the initiation of DNA replication [20] [21] [22] . Immunodepletion of Xenopus egg extracts using anti-XMCM3 antibodies removes a complex consisting of XMCM3 and presumed Xenopus homologues of MCM2 and MCM5/CDC46. This complex is not required for replication of permeabilized HeLa G-phase nuclei. However, permeabilized HeLa G2-phase nuclei are unable to replicate in an extract depleted of the 'MCM complex' [20] . This complex is therefore involved in distinguishing between the G1 and G2 states.
We have also shown, however, that the MCM complex does not fulfil one of the criteria for licensing factor, in that it can cross an intact nuclear envelope and bind to G1-phase chromatin [20] . So, why is permeabilization of the nuclear membrane required for a replicated nucleus to replicate again? We address this question here by looking at the regulation of binding of XMCM3 to chromatin. In addition, we examine the distribution of chromatin-bound XMCM3, and ask whether its loss from chromatin is dependent on replication.
Results
Sequence analysis of XMCM3
We have previously-described the cloning of XMCM3 [20] . The 2.6 kbp XMCM3 cDNA sequence is highly homologous to that of other MCM family members at both the nucleotide and predicted amino-acid levels ( Fig.  1 ), a conclusion that was corroborated by Kubota et al. [22] . The sequence contains an open reading frame of 2423 bp, encoding a protein of predicted molecular mass 90.4 kDa. The apparent discrepancy between this figure and the mass determined by SDS-PAGE (104 kDa) may be due to the high proportion of charged residues (34.8 %; pI 6.85) in the sequence. Unlike yeast MCM2 [24] , and in common with the other MCM3 homologues that have been identified so far, XMCM3 does not appear to have a zinc-finger motif, or indeed any other obvious DNA-binding domain.
Of the several regions rich in basic residues that are found in XMCM3, which may potentially serve as nuclear localization sequences (NLSs), none bears obvious similarity to the simian virus 40 (SV40) large T antigen NLS or to bipartite NLSs [25] . Other members of the complex may be responsible for providing a functional NLS.
Kimura et al. [18] have shown that the human MCM3 protein is phosphorylated during DNA replication. A MOTIFs search [26] shows that there are 10 potential phosphorylation sites for DNA-dependent protein kinase [27] within the sequence of XMCM3 (Fig. 1) . Strikingly, with the exception of a site at position 352, all of the sites are clustered in the final quarter of the protein. Figure 1 also shows other potential phosphorylation sites. The three S/T-P pairs (single-letter amino-acid code) within the sequence do not match the optimal consensus sequence (K/R-S/T-P-X-K/R) for phosphorylation by complexes made up of a cyclin and a cyclin-dependent kinase [28] . [19] ; S. cerevisiae MCM3 [24] ; human BM28 (MCM2) [11] ; S. cerevisiae CDC46 115]; S. pombe Cdc21 [13] ), centered on the MCM family signature sequence, IDEFDKM [43] , is shown above. Consensus sites for phosphorylation by protein kinase C, DNA-dependent protein kinase, cAMP/cGMP-dependent protein kinase and casein kinase II are indicated. [20] . All five proteins are recognized by an antibody directed against a conserved domain present throughout the MCM2/3/5 protein family [9] (a gift from R. Burkhart). The two right-hand lanes show that two sequential immunoprecipitations with anti-XMCM3 antibodies completely remove XMCM3 from extracts.
CDC21 is an additional component of the MCM complex
In an earlier publication [20] , we described XMCM3 as a component of a complex of at least four proteins in Xenopus egg extracts. We identified two other members of the complex as homologues of Saccharomyces cerevisiae MCM2 and MCM5 proteins [20] .
When the MCM3 complex from Xenopus egg extracts was immunoprecipitated and run further than previously on a 5 % polyacrylamide gel, another protein was clearly resolved (Fig. 2a) . Western immunoblot analysis allowed us to identify this new protein as the Xenopus homologue of human CDC21 [29] (which is itself a homologue of Schizosaccharomyces pombe Cdc21 [13] ) (Fig. 2b) . Furthermore, immunoblots of mock immunoprecipitations probed with anti-human-CDC21 antibodies did not give a signal (data not shown), implying that this antibody recognizes a protein that is specific to the complex. This protein also cross-reacts with an antibody raised against the central conserved region of the MCM family of proteins [9] . Three of the four remaining bands correspond to proteins that we have previously identified as homologues of MCMs 2, 3 and 5. The anti-XMCM3 antibodies react specifically only with XMCM3 on immunoblots ( Fig. 2b ; [20] ), suggesting that the Xenopus homologues of MCM2, MCM5 and CDC21 are present in a complex with XMCM3 in egg extracts and are not cross-reacting antigens.
Binding of XMCM3 to chromatin during replication
Previously, murine, human and Xenopus MCM3 proteins have been shown to bind to chromatin before the initiation of DNA replication, and to become displaced during replication ( [18, [20] [21] [22] ; T. Krude, C. Musahl, R.A.L. and R. Knippers, personal communication). Interestingly, XMCM3 binds to sperm chromatin before the formation of the nuclear membrane and before replication protein A (RPA) binds and forms pre-replication initiation complexes [22] .
We have used confocal microscopy to monitor the sub-nuclear localization of XMCM3 before and during replication. Figure 3a confirms that the binding of XMCM3 to Xenopus sperm chromatin precedes the formation of an intact nuclear envelope; it also shows that the staining pattern is neither homogeneous nor discretely punctate. In contrast, DNA staining with Hoechst 33258 was homogeneous within nuclei at all time points (data not shown). As replication proceeded, there was a rapid decrease in XMCM3 nuclear immunofluorescence ( Fig. 3b,c ; green). The same results were obtained when nuclei were washed in a detergent-containing buffer before fixation to select for tightly bound XMCM3 (data not shown).
As XMCM3 is essential for DNA replication [20] [21] [22] , we determined whether the chromatin-bound protein colocalized to sites of replication in Xenopus sperm nuclei. Nuclei were harvested at a time when DNA synthesis was first visible, as detected by biotin-dUTP incorporation (Fig. 3b) . The results show that these sites of replication initiation (red in Fig. 3 ) do not preferentially co-localize with XMCM3 (green in Fig. 3 ). Co-localization would result in the appearance of yellow merged images, as for the co-localization of RPA with sites of replication initiation ( Fig. 3d ; [30] ). Surprisingly, XMCM3 did not co-localize with sites of initiation or elongation. Instead, XMCM3 immunofluorescence was preferentially excluded from replicated DNA throughout S phase (Fig. 3b ,c and data not shown).
XMCM3 immunofluorescence decreases suddenly during replication
It has been demonstrated previously that the loss of chromatin-bound XMCM3 from a population of nuclei during replication is gradual [20, 21] . Apparently, the proportion of XMCM3 that is bound to chromatin directly correlates with the amount of unreplicated DNA [21] . However, these experiments present only an average from a population of nuclei, and give no information on the level of XMCM3 in individual nuclei during replication. Here, we have used immunofluorescence to monitor the amount of XMCM3 bound to chromatin in individual nuclei. Our results show a clear difference from those previously reported. Consistent with the data shown in Figure 3 and previous results [20, 21] , XMCM3 is bound to chromatin before initiation and is lost by 60 minutes (Fig. 4b) . However, in contrast to previous results, we found that the loss of XMCM3 from chromatin was not gradual. Instead, XMCM3 remained bound at high levels for at least another 10 minutes (Fig.  4b) . During this time sperm chromatin continued to replicate efficiently (Fig. 4a) . This was followed by a sudden drop in the amount of XMCM3 bound to individual nuclei ( Fig. 4b; 40-45 minutes) . This residual low level of bound XMCM3 was gradually lost during the remaining period of S phase. At 60 minutes, all nuclei had lost XMCM3 and 96 % had completed S phase (Fig. 4a,b) .
Effect of aphidicolin on chromatin-bound XMCM3
Our results illustrate that most of the XMCM3 is lost from chromatin after a lag of 10 minutes following replication initiation. It has previously been reported that the addition of aphidicolin, an inhibitor of DNA replication, blocks the loss of XMCM3 from chromatin [21, 22] . If DNA replication is causing the loss of XMCM3 from chromatin, then aphidicolin should prevent that loss. Figure 5a shows that addition of aphidicolin at various stages throughout S phase efficiently blocked DNA synthesis in egg extract. Figure 5b shows that the addition of aphidicolin at the start of the incubation completely prevented the release of XMCM3 from chromatin. The addition of aphidicolin at later stages blocked subsequent release partially, but not completely. Thus, when aphidicolin was added at 30 minutes and the incubation continued to 60 minutes, XMCM3 immunofluorescence fell to 24 % of its peak value. In the absence of aphidicolin, immunofluorescence would have disappeared completely (Figs 4b,5b) ; alternatively, it would have remained at 100 % if the incubation was stopped at the time of aphidicolin addition (compare Figs 4b,5b) . When aphidicolin was added at 40 minutes, XMCM3 immunofluorescence completely disappeared over the next 20 minutes, from a value of 78 % at the time of addition (Figs 4b,5b) .
A detailed comparison-of Figures 4 and 5 shows that 76 % of the chromatin-bound XMCM3 immunofluorescence was lost when only 10% of DNA had been replicated, but that release was delayed by a mechanism that was not aphidicolin-sensitive. This is consistent with initiation, rather than elongation, being the trigger for the release of XMCM3. As the cells of Xenopus embryos may initiate replication synchronously, it will be interesting to see how this behaviour compares with that of cultured mammalian cells, in which the delayed initiation of replication at some sites in a nucleus has been clearly established.
XMCM3 accumulates in intact G2-phase HeLa nuclei but is unable to bind to chromatin Gl-phase, but not intact G2-phase, nuclei are competent to replicate their DNA in Xenopus egg extract [2, 3, 31] . We have demonstrated previously that the Xenopus MCM protein complex is essential for DNA replication [20] . Interestingly, HeLa Gl-phase, but not HeLa G2-phase, nuclei contain an active, chromatin-bound XMCM complex [20] . However, permeabilization of the nuclear envelope of G2-phase nuclei is sufficient to bring about reinitiation of DNA replication in Xenopus egg extract, provided that the XMCM complex is present [2, 3, 20, 31] . One possible explanation for these results is that the nuclear envelope prevents XMCM3 from entering the nucleus, as has been seen in yeast [8, 15, 17] and as would be predicted if XMCM3 completely fulfills the role of the licensing factor postulated by Blow and Laskey [2] . Consistent with this possibility, Kubota et al. [22] reported that an XMCM3 fusion protein was unable to cross the nuclear envelope. In contrast, however, we found that the native XMCM complex appeared to be able to cross an intact nuclear envelope and to rescue DNA replication of a nucleus that had been exposed previously to a depleted extract [20] .
To resolve this confusing situation, we tested the hypothesis that a permeable nuclear membrane is not required in order to allow entry of XMCM3 into the nucleus, but is required for XMCM3 to bind to chromatin. We took advantage of the fact that HeLa G2-phase nuclei do not cross-react with anti-XMCM3 antibodies, as judged by immunofluorescence (Fig. 6a) . Intact HeLa G2-phase nuclei incubated in egg extract accumulated XMCM3 but did not replicate (Fig. 6b) . This result demonstrates that the nuclear envelope does not control DNA replication by preventing the entry of XMCM3 into the nucleus. In contrast, permeabilized G2-phase nuclei underwent efficient DNA replication and accumulated XMCM3 to a greater extent (Fig. 6b ).
To test whether or not XMCM3 which had crossed an intact nuclear envelope could bind to chromatin, HeLa G2-phase nuclei were incubated in egg extract and washed with a detergent-containing buffer before fixation. When nuclei with intact nuclear envelopes are treated in this way, we observed a clear loss of immunofluorescence (Fig. 6c) . In contrast, when permeabilized nuclei were treated the same way, XMCM3 remained tightly bound to the chromatin (Fig. 6c) . Similar results were seen with replicated Xenopus sperm nuclei (data not 6 . The nuclear envelope does not prevent entry of XMCM3 into the nucleus, but does regulate the binding of XMCM3 to chromatin. Intact (top panels) or permeabilized (lower panels) HeLa G2-phase nuclei were: (a) stained without incubation; (b) incubated with biotin-dUTP in egg extract for 1 h; or (c) treated as in (b) followed by detergent washing. Samples were stained for DNA (white), XMCM3 (green) and replication (biotin-dUTP incorporation; red) and viewed by fluorescence microscopy. Both intact and permeabilized nuclei accumulated XMCM3 (b), but XMCM3 could bind to the G2-phase chromatin only in permeabilized nuclei (c).
shown). These results illustrate three critical points. First, the nuclear envelope does not prevent nuclear entry of XMCM3. Second, the nuclear envelope does regulate binding of XMCM3 to chromatin. Third, initiation of DNA replication is seen only when XMCM3 is bound to chromatin.
We have not investigated why a bacterially expressed XMCM3 fusion protein failed to cross the nuclear envelope [22] . These results could be explained if there was a protein-folding problem, or if NLS function was disrupted by labelling with flourescein isothiocyanate. A more interesting possibility is that a different member of the XMCM protein complex might be responsible for transporting the whole complex into the nucleus.
The nuclear envelope regulates the binding of XMCM3 to chromatin via a second component
We have shown previously that unreplicated sperm nuclei incubated in an extract from which XMCM3 has been depleted fail to replicate. However, when they are subsequently transferred to an undepleted extract, XMCM3 crosses the intact nuclear envelope, binds to the chromatin and permits DNA replication [20] . This contrasts with the inability of XMCM3 to bind to the chromatin of intact HeLa G2-phase nuclei. The difference in results could be explained if a second component is required, and is unable to cross the nuclear envelope but is essential for allowing XMCM3 to bind to chromatin. Exclusion of this second component from an intact nucleus would explain why XMCM3 is able to cross an intact nuclear envelope but is not able to bind to replicated chromatin, or to allow it to replicate again.
To test this possibility, we asked whether preincubation of replicated HeLa G2-phase chromatin with extract (depleted of the XMCM complex before repair of the nuclear envelope) was sufficient to allow the binding of XMCM3 to chromatin. Permeabilized G2-phase nuclei were preincubated with an XMCM3-depleted extract; in this extract, neither intact nor permeabilized G2-phase nuclei could replicate ( Fig. 7a,c ; [20] ). Following nuclear membrane repair and transfer to mock-depleted extract, XMCM3 was able to cross the nuclear membrane and bind to the chromatin. Biotin-dUTP incorporation (Fig.  7b) showed that these nuclei could replicate efficiently, and density substitution (Fig. 7c) showed that a single round of semi-conservative replication had occurred.
These results clearly demonstrate that the control of DNA replication is not regulated by limiting the nuclear import of XMCM3. Intact nuclei preincubated in an XMCM3-depleted extract and transferred to mockdepleted extract lack chromatin-bound XMCM3 and do not replicate (Fig. 7b,c) . Figure 7c illustrates the clear difference in replication capacity between permeabilized and intact nuclei preincubated in XMCM3-depleted extract and transferred to mock-depleted extract. This indicates that a second component in the egg extract must allow XMCM3 to bind to chromatin and permit DNA replication. The inability of intact G2-phase HeLa nuclei to bind XMCM3 (Figs 6c,7b) suggests that this second component cannot cross the nuclear envelope.
Discussion
Composition and location of the MCM complex in Xenopus eggs
We have shown previously that three different polyclonal antibodies against Xenopuis MCM3 all immunoprecipitate a complex containing Xenopus homologues of yeast MCMs 2, 3 and 5 [20] . All three anti-XMCM3 antibodies are monospecific on western immunoblots, Fig. 7 . Binding of XMCM3 to chromatin requires a second activity which cannot cross the nuclear envelope. (a) Intact or permeabilized HeLa G2-phase nuclei were incubated with biotin-dUTP in XMCM3-depleted extract -they did not stain for XMCM3 or replicate. (b) Following repair of the nuclear envelope during incubation as in (a), nuclei were transferred to mock-depleted egg extract supplemented with biotin-dUTP for 1 h and subsequently detergentwashed. Samples were then fixed and stained for DNA (white), XMCM3 (green) and replication (red), and viewed by fluorescence microscopy. (c) Density substitution gradients illustrate a clear difference in replication capacity between permeabilized and intact HeLa G2-phase nuclei following the procedures described in (a) and (b). Extracts before and after transfer were supplemented with a-[ showing that precipitation is cause by the presence of these proteins in a complex, rather than as a result of antibody cross-reaction. Here, we have identified a further member of the complex as the Xenopus homologue of the S. pombe Cdc21 protein (Fig. 2) . Our observation that a complex of MCM proteins is present in Xenopus eggs has been corroborated and has been observed in a range of other cells [21, 22, 29, 32] , although in some cases two discrete subcomplexes have been observed. Figure 1 illustrates the degree of sequence conservation between members of this complex, even across species barriers.
The MCM complex is essential for the initiation of DNA replication in Xenopus egg extracts [20] [21] [22] . DNA replication in extracts is known to occur at discrete replication foci [30, [33] [34] [35] [36] . The MCM complex might therefore be expected to concentrate at replication foci at some point in the replication cycle. However, Figure 3 shows that MCM3 is not preferentially localized at sites of DNA replication; instead, it is almost uniformly distributed on the chromatin and erased from the sites of replication.
Behaviour of MCM proteins during the cell cycle MCM proteins were discovered in S. cerevisiae and named because of their involvement in mini-chromosome maintenance [6] . Their involvement in DNA replication [7] and their exclusion from the nucleus until anaphase of mitosis [15, 17] suggested that they might be good candidates for the hypothetical licensing factor proposed by Blow and Laskey [2] . However, although there is evidence that they are required for replication licensing [20] [21] [22] , the MCM proteins of higher eukaryotes appear to be nuclear throughout the cell cycle ( [10, 11, 18, 19] ; T. Krude, C. Musahl, R.A.L. and R. Knippers, personal communication). Instead of their presence or absence in the nucleus varying through the cell cycle, their binding to chromatin varies ( [18, 23] ; T. Krude, C. Musahl, R.A.L. and R. Knippers, personal communication). As replication proceeds, MCM3 is displaced from chromatin, but in vivo it remains in the nucleus in a soluble, detergent-extractable form ( Fig. 4 ; [18, [20] [21] [22] [23] ; T. Krude, C. Musahl, R.A.L. and R. Knippers, personal communication). Figure 5 shows that DNA replication is required for the displacement of XMCM3 from chromatin. It also shows that 76 % of the chromatin-bound XMCM3 immunofluorescence is lost when only 10 % of the chromatin has replicated. These results should be interpreted with caution, as we cannot rule out the possibility that the early loss in fluorescence is a side effect of stalling replication forks following prolonged incubation in aphidicolin. This possibility seems unlikely, however, because the subsequent removal of aphidicolin has no effect on the progression of replication forks [37] . The results shown in Figure 5 support the possibility that XMCM3 displacement is triggered by an early event in replication, possibly initiation itself, but that release is delayed. Once displacement has been triggered by an early replication event, then the delay before release is independent of DNA replication (Fig. 5 ). It will be interesting to see whether the delay corresponds to a chromatin maturation event or is mediated by the phosphorylation of MCM proteins when they are displaced [18, 23] :
The nuclear membrane restricts binding of XMCM3 to chromatin, but not its entry into the nucleus Permeabilizing the nuclear membrane allows replicated nuclei to replicate their DNA again [2, 3, 31] . We have shown previously that XMCM3 can cross the intact membrane of an unreplicated sperm nucleus. Figure 6 shows that this is also true of a replicated HeLa G2-phase nucleus. Therefore, the critical effect of permeabilizing a G2-phase nucleus cannot be to allow entry of XMCM3.
Kubota et al. [22] showed that a bacterially expressed XMCM3 fusion protein was unable to cross the nuclear membrane. The most interesting explanation for this difference between the fusion protein and the endogenous complex is that another MCM protein in the complex contains a signal that transports the whole complex into the nucleus. This possibility remains to be tested.
Although nuclear membrane permeabilization is not required for entry of XMCM3, it is required for XMCM3 to bind to chromatin (Figs 6,7) . The ability of G2-phase nuclei to reinitiate replication coincides with the binding of XMCM3 to chromatin and does not occur when the XMCM complex is immunodepleted (Figs 6,7) . Figure 7 shows that a second cytosolic loading factor is required for XMCM3 to bind to chromatin, and that this Fig 8. A two-stage model for 'replication licensing' [2, 41] . The MCM protein complex, acting as the 'licence', can cross the nuclear envelope throughout interphase. However, cytosolic 'loading factor' is excluded from the chromatin by an intact nuclear envelope during interphase. The loading factor can enter the nucleus only during mitosis, allowing MCM3 to bind chromatin at any point between mitosis and S phase. Loading factor must be inactivated before or during initiation of DNA replication to explain why MCM3 is unable to bind replicated chromatin during S or G2 phases (Figs 6,7 ; [18, [20] [21] [22] ). The persistence of an intact nuclear envelope until mitosis prevents further binding of MCM3 until nuclear envelope breakdown, thereby limiting DNA replication to once per cell cycle. second factor is excluded by the nuclear membrane. A prime candidate for the loading factor is fraction RLF-B, which is also required for licensing [21] . Therefore, as summarized in Figure 8 , licensing can be resolved into two separate steps and only the first requires a permeable nuclear membrane. The two stages of licensing can be likened to the sequential-need for a ticket and a boarding pass to board an aircraft. The loading factor (or 'ticket') is required in order to obtain the MCM complex (or 'boarding pass'), which then allows a single round of replication (or 'flight') and is surrendered on use. It is possible to debate semantically which of these two factors should be called the 'licensing factor', but this ambiguity could cause confusion. We therefore suggest that the name 'licensing factor' should be discontinued, to avoid confusion, but that the term 'replication licensing' should continue.
A two-stage model of replication licensing
Materials and methods
Preparation of extract and nuclei
Low-and high-speed Xenopus egg extracts were prepared essentially as reported [38, 39] . The preparation of demembranated sperm nuclei has been described previously [38] . Synchronous HeLa G2-phase cells were prepared essentially as in [31] . Intact nuclei were prepared as described, with the exception that all incubations were carried out in HE buffer (50 mM Hepes-KOH, pH 7.4; 50 mM KCI; 5 mM MgC1 2 ; 1 mM EGTA; 1 mM DTT; I pg ml -aprotinin, pepstatin, leupeptin and chymostatin).
Nuclear membrane permeabilization
Streptolysin O-prepared HeLa G2-phase nuclei [31] and replicated Xenopus sperm nuclei were incubated with 1001 gml-' lysolecithin (Sigma Immunochemicals) in HE buffer at a concentration of approximately 5 x 105 nuclei per ml, for 10 min at 23 °C with occasional gentle mixing. Reactions were stopped by the addition of 3 % nuclease-free BSA (Sigma Chemicals). Nuclei were gendtly pelleted at 600 x g for 10 min, resuspended in HE buffer and overlayed onto a step of 30 % sucrose in HE buffer. Nuclei were pelleted and resuspended in a small volume of 30 % sucrose in HE buffer to approximately 1 x 104 nuclei per J.
Replication reactions
Aliquots of frozen extract were thawed at 23 C and supplemented immediately with an ATP-regenerating system (10 mM creatine phosphate (Boehringer Mannheim); 20 Jtg ml -l creatine phosphokinase (Boehringer Mannheim); 1 mM ATP (Sigma); 1 mM MgC1 2 ; mM GTP (Boehringer Mannheim); 5 mM Hepes, pH 7.5; 1 mM DTT). Extracts were depleted using anti-XMCM3 antibodies, as described previously [20] . Mock depletions were carried out using protein A-Sepharose-conjugated rabbit anti-rat IgG. Extracts were then supplemented with DNA (3-5 ng sperm or 500 HeLa Incubations in XMCM3-depleted extract were transferred to mock-depleted extract by dilution in a 10-fold excess of mockdepleted extract (Fig. 7) . Nuclear membrane integrity was monitored by supplementing incubations with fluoresceinlabelled nucleoplasmin core fragment [40] immediately before transfer to mock-depleted extract. Nuclei were checked for integrity following transfer.
TCA precipitation and density substitution
For measurement of ct-[ 3 2 P]dATP incorporation into DNA (Fig. 5a ), duplicate 1 pl samples were dried onto Whatman GF/C filter papers, precipitated with TCA, washed with ethanol, dried, and counted in Optiphase scintillation fluid (Wallace). Quantification of DNA replication was based on the assumption that the dATP pool size in the extract is 50 JtM [41] . For density substitution, reactions were stopped by the addition of 80 1 buffer containing 0.5 % SDS, 20 mM Hepes-KOH (pH 7.4) and 20 mM EDTA. After incubation for h at 37 °C with 1 mg ml -l proteinase K (Sigma), reactions were extracted three times with phenol/chloroform. DNA was then fractionated on caesium chloride gradients, as described previously [38] .
Microscopy
Samples were diluted in 500 p1 extract buffer (EB, [41] ) or 500 pl detergent-wash buffer (EB supplemented with 0.1 % Triton X-100; Sigma). A further 500 p1 of 10 % formalin solution was added and samples were incubated at room temperature for 10 min with gentle mixing. Nuclei were spun onto coverslips [33] and stained for biotin-dUTP, RPA and XMCM3 using the procedure described previously [42] . XMCM3 immunofluorescence was quantified by comparing fluorescence intensities collected at identical settings on the scanning laser confocal microscope (BioRad MRC600). Data representing total pixel intensities across the equatorial plane of each nucleus were estimated with NIH Image software.
Immunoprecipitations
Immunoprecipitations were carried out as described previously [20] . Protein A-Sepharose beads cross-linked with rabbit anti-XMCM3 antibodies were incubated for 1 h with Xenopus egg extract. Beads were washed ten times in a 50-fold volume of EB over a period of 1 h at 4 °C. Beads were recovered by centrifugation, and samples were subjected to 5 % SDS-PAGE. Gels were either Coomassie stained or immunoblotted. Immunoreactive proteins were detected by ECL (Amersham).
